Fonar Corporation  

(Public, NASDAQ:FONR)   Watch this stock  
Find more results for FONR
19.75
-0.55 (-2.71%)
Jan 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 19.70 - 20.45
52 week 12.76 - 23.90
Open 20.15
Vol / Avg. 8,145.00/26,018.00
Mkt cap 129.50M
P/E 8.40
Div/yield     -
EPS 2.35
Shares 6.16M
Beta 2.43
Inst. own 40%
Feb 7, 2017
Q2 2017 Fonar Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 9, 2016
Q1 2017 Fonar Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin 24.02% 25.62%
Operating margin 25.37% 19.57%
EBITD margin - 24.06%
Return on average assets 21.11% 23.29%
Return on average equity 24.25% 32.39%
Employees 501 -
CDP Score - -

Address

110 Marcus Dr
MELVILLE, NY 11747-4228
United States - Map
+1-631-6942929 (Phone)
+1-631-7535150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment. Its Medical Equipment segment is conducted through Fonar. Its Physician Management and Diagnostic Services segment is conducted through its subsidiary Health Management Company of America (HMCA). It offers Upright MRI, which is used to scan any part of the body. The Upright MRI allows patients to be scanned in various conditions, such as standing, sitting, bending or lying down in any position. The Company offers SMART, where scanning allows for same-scan customization of 63 slices.

Officers and directors

Raymond V. Damadian Chairman of the Board
Age: 79
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy R. Damadian President, Chief Executive Officer
Age: 44
Bio & Compensation  - Reuters
Claudette J. V. Chan Secretary, Director
Age: 77
Bio & Compensation  - Reuters
Charles N. O'Data Lead Independent Director
Age: 79
Bio & Compensation  - Reuters
Robert J. Janoff Independent Director
Age: 88
Bio & Compensation  - Reuters
Ronald G. Lehman Independent Director
Age: 39
Bio & Compensation  - Reuters